HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maciej Szmitkowski Selected Research

Tumor Biomarkers (Tumor Markers)

6/2020Possible Diagnostic Application of CXCL12 and CXCR4 as Tumor Markers in Breast Cancer Patients.
4/2020Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC Analysis.
3/2020Can VEGFR-3 be a better tumor marker for breast cancer than CA 15-3?
10/2019Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer.
5/2019Diagnostic Power of Selected Cytokines, MMPs and TIMPs in Ovarian Cancer Patients - ROC Analysis.
4/2019Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers.
1/2019Matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor 2 (TIMP-2) in pancreatic cancer (PC).
12/2018Plasma levels of VEGF-A, VEGF B, and VEGFR-1 and applicability of these parameters as tumor markers in diagnosis of breast cancer.
7/2018Plasma levels and diagnostic utility of macrophage-colony stimulating factor, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 as tumor markers in cervical cancer patients.
1/2018Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maciej Szmitkowski Research Topics

Disease

106Neoplasms (Cancer)
11/2021 - 01/2002
32Breast Neoplasms (Breast Cancer)
11/2021 - 01/2003
23Carcinogenesis
05/2017 - 06/2004
22Neoplasm Metastasis (Metastasis)
03/2019 - 08/2005
19Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 01/2002
18Alcoholism (Alcohol Abuse)
09/2010 - 06/2004
15Stomach Neoplasms (Stomach Cancer)
08/2016 - 12/2006
14Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 03/2004
14Esophageal Neoplasms (Esophageal Cancer)
10/2017 - 01/2008
13Liver Diseases (Liver Disease)
07/2018 - 11/2009
12Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2020 - 01/2007
8Carcinoma (Carcinomatosis)
03/2019 - 01/2007
8Endometrial Neoplasms (Endometrial Cancer)
09/2013 - 01/2007
7Ovarian Neoplasms (Ovarian Cancer)
05/2019 - 11/2006
7Fibrosis (Cirrhosis)
07/2018 - 01/2008
6Pancreatitis
01/2018 - 03/2004
6Chronic Pancreatitis
01/2018 - 03/2004
6Inflammation (Inflammations)
08/2016 - 01/2008
6Adenoma (Adenomas)
12/2010 - 09/2006
5Hypertension (High Blood Pressure)
10/2010 - 07/2007
5Alcoholic Liver Diseases (Alcoholic Liver Disease)
06/2010 - 06/2008
4Psoriasis (Pustulosis Palmaris et Plantaris)
04/2018 - 01/2016
4Renal Cell Carcinoma (Grawitz Tumor)
03/2018 - 05/2007
4Liver Cirrhosis (Hepatic Cirrhosis)
01/2017 - 11/2009
4Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2016 - 03/2008
4Infections
10/2014 - 05/2004
4Cardiovascular Diseases (Cardiovascular Disease)
04/2011 - 07/2007
4ST Elevation Myocardial Infarction
01/2011 - 11/2006
4Liver Neoplasms (Liver Cancer)
09/2008 - 03/2006
3Sepsis (Septicemia)
05/2019 - 11/2008
3Myocardial Infarction
02/2019 - 11/2006
3Urinary Bladder Neoplasms (Bladder Cancer)
01/2018 - 01/2017
3Ovarian Epithelial Carcinoma
06/2017 - 12/2012
3Brain Neoplasms (Brain Tumor)
03/2017 - 07/2013
3Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
01/2017 - 11/2009
3Alzheimer Disease (Alzheimer's Disease)
01/2015 - 01/2014
3Dementia (Dementias)
01/2015 - 01/2014
3Myoma
02/2012 - 06/2009
3Asthma (Bronchial Asthma)
01/2010 - 01/2007
3Bronchial Hyperreactivity
01/2010 - 01/2007
3Uterine Neoplasms (Uterine Cancer)
06/2009 - 01/2007
3Disease Progression
09/2008 - 07/2004
2Septic Shock (Toxic Shock Syndrome)
05/2019 - 08/2018
2Adenocarcinoma
04/2019 - 02/2012
2Uterine Cervical Dysplasia
04/2019 - 07/2012

Drug/Important Bio-Agent (IBA)

61Tumor Biomarkers (Tumor Markers)IBA
06/2020 - 01/2002
45Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA
07/2018 - 07/2002
43IsoenzymesIBA
07/2018 - 07/2002
41EnzymesIBA
07/2018 - 11/2003
38Aldehyde DehydrogenaseIBA
07/2018 - 06/2004
35CytokinesIBA
06/2020 - 04/2002
32Macrophage Colony-Stimulating FactorIBA
04/2020 - 04/2002
25Biomarkers (Surrogate Marker)IBA
04/2021 - 06/2004
23Matrix Metalloproteinases (MMPs)IBA
04/2021 - 03/2008
19Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2012 - 04/2002
17AntigensIBA
12/2020 - 04/2002
16squamous cell carcinoma-related antigenIBA
04/2020 - 01/2007
16N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2016 - 06/2004
15Ethanol (Ethyl Alcohol)IBA
05/2017 - 11/2003
14C-Reactive ProteinIBA
05/2019 - 07/2002
13Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2021 - 01/2007
13Matrix Metalloproteinase 9 (Gelatinase B)IBA
03/2019 - 01/2008
12Metalloproteases (Metalloproteinases)IBA
12/2020 - 04/2008
12CarbohydratesIBA
05/2017 - 04/2002
12AcetaldehydeIBA
05/2017 - 11/2003
12Proteins (Proteins, Gene)FDA Link
05/2017 - 09/2007
12Carcinoembryonic AntigenIBA
02/2012 - 04/2002
11Tissue Inhibitor of Metalloproteinase-1IBA
03/2019 - 01/2009
11Stem Cell FactorIBA
10/2017 - 05/2003
10Tissue Inhibitor of Metalloproteinase-2IBA
04/2020 - 07/2010
10theasinensin AIBA
11/2014 - 08/2005
10Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2012 - 05/2003
9Interleukin-6 (Interleukin 6)IBA
05/2019 - 05/2007
9Transferrin (beta 2 Transferrin)IBA
05/2017 - 01/2006
9LipidsIBA
01/2016 - 08/2005
9A-factor (Streptomyces)IBA
07/2013 - 06/2004
7Matrix Metalloproteinase 2 (Gelatinase A)IBA
04/2020 - 12/2010
7carbohydrate-deficient transferrinIBA
09/2016 - 01/2006
7Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2012 - 05/2003
6ImmunosorbentsIBA
07/2018 - 06/2009
6IronIBA
04/2015 - 06/2006
6Peroxidase (Myeloperoxidase)IBA
01/2010 - 02/2004
5ChemokinesIBA
06/2020 - 08/2015
5Protein Isoforms (Isoforms)IBA
05/2017 - 01/2006
5Glycoproteins (Glycoprotein)IBA
03/2014 - 06/2007
5Interleukin-3 (Interleukin 3)IBA
01/2007 - 05/2003
4Collagen Type IV (Type IV Collagen)IBA
03/2016 - 01/2008
4Brain Natriuretic Peptide (Natrecor)FDA Link
01/2011 - 11/2006
4Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2010 - 01/2007
3Triglycerides (Triacylglycerol)IBA
01/2016 - 07/2007
3Apolipoproteins B (ApoB)IBA
01/2016 - 06/2008
3Lipoproteins (Lipoprotein)IBA
01/2016 - 06/2008
3Sialic AcidsIBA
11/2014 - 01/2006
3SelectinsIBA
01/2010 - 01/2008
3antigen CYFRA21.1IBA
02/2009 - 01/2007
2ProcalcitoninIBA
05/2019 - 08/2018
2Triggering Receptor Expressed on Myeloid Cells-1IBA
05/2019 - 08/2018

Therapy/Procedure

8Therapeutics
01/2018 - 08/2005
7Drug Therapy (Chemotherapy)
01/2008 - 07/2004
3Radiotherapy
10/2012 - 07/2004